These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 32687159)

  • 1. Sex-Specific Metabolite Biomarkers of NAFLD in Youth: A Prospective Study in the EPOCH Cohort.
    Perng W; Francis EC; Smith HA; Carey J; Wang D; Kechris KM; Dabelea D
    J Clin Endocrinol Metab; 2020 Sep; 105(9):e3437-50. PubMed ID: 32687159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic fat and β-cell function in overweight/obese children with nonalcoholic fatty liver disease.
    Pacifico L; Di Martino M; Anania C; Andreoli GM; Bezzi M; Catalano C; Chiesa C
    World J Gastroenterol; 2015 Apr; 21(15):4688-95. PubMed ID: 25914480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Adolescent Obesity with Nonalcoholic Fatty Liver Disease and Related Risk Factors in Xi 'an, China.
    Rong Y; Chun-Yan N; Hong-Xin Z; Lu Y; Wen W; Yu T
    Ann Hepatol; 2018; 17(1):85-91. PubMed ID: 29311392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse metabolic phenotype of adolescent girls with non-alcoholic fatty liver disease plus polycystic ovary syndrome compared with other girls and boys.
    Ayonrinde OT; Adams LA; Doherty DA; Mori TA; Beilin LJ; Oddy WH; Hickey M; Sloboda DM; Olynyk JK; Hart R
    J Gastroenterol Hepatol; 2016 May; 31(5):980-7. PubMed ID: 26589977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High fat diet incorporated with meat proteins changes biomarkers of lipid metabolism, antioxidant activities, and the serum metabolomic profile in Glrx1
    Ahmad MI; Umair Ijaz M; Hussain M; Ali Khan I; Mehmood N; Siddiqi SM; Liu C; Zhao D; Xu X; Zhou G; Li C
    Food Funct; 2020 Jan; 11(1):236-252. PubMed ID: 31956867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum metabolites detect the presence of advanced fibrosis in derivation and validation cohorts of patients with non-alcoholic fatty liver disease.
    Caussy C; Ajmera VH; Puri P; Hsu CL; Bassirian S; Mgdsyan M; Singh S; Faulkner C; Valasek MA; Rizo E; Richards L; Brenner DA; Sirlin CB; Sanyal AJ; Loomba R
    Gut; 2019 Oct; 68(10):1884-1892. PubMed ID: 30567742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased circulating zonulin in children with biopsy-proven nonalcoholic fatty liver disease.
    Pacifico L; Bonci E; Marandola L; Romaggioli S; Bascetta S; Chiesa C
    World J Gastroenterol; 2014 Dec; 20(45):17107-14. PubMed ID: 25493023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Fatty Liver Index and Metabolic Factors in the Prediction of Nonalcoholic Fatty Liver Disease in a Lean Population Receiving Health Checkup.
    Hsu CL; Wu FZ; Lin KH; Chen YH; Wu PC; Chen YH; Chen CS; Wang WH; Mar GY; Yu HC
    Clin Transl Gastroenterol; 2019 May; 10(5):1-8. PubMed ID: 31082856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Branched-Chain Amino Acid-Related Metabolic Signature Characterizes Obese Adolescents with Non-Alcoholic Fatty Liver Disease.
    Goffredo M; Santoro N; Tricò D; Giannini C; D'Adamo E; Zhao H; Peng G; Yu X; Lam TT; Pierpont B; Caprio S; Herzog RI
    Nutrients; 2017 Jun; 9(7):. PubMed ID: 28640216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatty liver index vs waist circumference for predicting non-alcoholic fatty liver disease.
    Motamed N; Sohrabi M; Ajdarkosh H; Hemmasi G; Maadi M; Sayeedian FS; Pirzad R; Abedi K; Aghapour S; Fallahnezhad M; Zamani F
    World J Gastroenterol; 2016 Mar; 22(10):3023-30. PubMed ID: 26973398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender-specific differences in clinical and metabolic variables associated with NAFLD in a Mexican pediatric population.
    Villanueva-Ortega E; Garcés-Hernández MJ; Herrera-Rosas A; López-Alvarenga JC; Laresgoiti-Servitje E; Escobedo G; Queipo G; Cuevas-Covarrubias S; Garibay-Nieto GN
    Ann Hepatol; 2019; 18(5):693-700. PubMed ID: 31151875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mass-Spectrometry-Based Serum Metabolomics of a C57BL/6J Mouse Model of High-Fat-Diet-Induced Non-alcoholic Fatty Liver Disease Development.
    Lai YS; Chen WC; Kuo TC; Ho CT; Kuo CH; Tseng YJ; Lu KH; Lin SH; Panyod S; Sheen LY
    J Agric Food Chem; 2015 Sep; 63(35):7873-84. PubMed ID: 26262841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of Nonalcoholic Fatty Liver Disease in Children with Obesity.
    Yu EL; Golshan S; Harlow KE; Angeles JE; Durelle J; Goyal NP; Newton KP; Sawh MC; Hooker J; Sy EZ; Middleton MS; Sirlin CB; Schwimmer JB
    J Pediatr; 2019 Apr; 207():64-70. PubMed ID: 30559024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene-metabolite network analysis in different nonalcoholic fatty liver disease phenotypes.
    Liu XL; Ming YN; Zhang JY; Chen XY; Zeng MD; Mao YM
    Exp Mol Med; 2017 Jan; 49(1):e283. PubMed ID: 28082742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic analysis of early nonalcoholic fatty liver disease in humans using liquid chromatography-mass spectrometry.
    Hu C; Wang T; Zhuang X; Sun Q; Wang X; Lin H; Feng M; Zhang J; Cao Q; Jiang Y
    J Transl Med; 2021 Apr; 19(1):152. PubMed ID: 33858428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endotoxin biomarkers, hepatic fat fraction, liver volume and liver stiffness among adolescents at high-risk for non-alcoholic fatty liver disease: The HEROES study.
    Perng W; Salmon K; Schenker R; Janssen RC; Friedman JE; Goran MI
    Pediatr Obes; 2024 Feb; 19(2):e13091. PubMed ID: 38084670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of non-alcoholic fatty liver disease (NAFLD) among children with obesity.
    Mohamed RZ; Jalaludin MY; Anuar Zaini A
    J Pediatr Endocrinol Metab; 2020 Feb; 33(2):247-253. PubMed ID: 31926095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying Nonalcoholic Fatty Liver Disease Advanced Fibrosis in the Veterans Health Administration.
    Patel YA; Gifford EJ; Glass LM; Turner MJ; Han B; Moylan CA; Choi S; Suzuki A; Provenzale D; Hunt CM
    Dig Dis Sci; 2018 Sep; 63(9):2259-2266. PubMed ID: 29779083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of MR proton density fat fraction and its correlation with ultrasonography and biochemical markers in nonalcoholic fatty liver disease in overweight adolescents.
    Netaji A; Jain V; Gupta AK; Kumar U; Jana M
    J Pediatr Endocrinol Metab; 2020 Apr; 33(4):473-479. PubMed ID: 32146441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial dysfunction as a mechanistic biomarker in patients with non-alcoholic fatty liver disease (NAFLD).
    Ajaz S; McPhail MJ; Gnudi L; Trovato FM; Mujib S; Napoli S; Carey I; Agarwal K
    Mitochondrion; 2021 Mar; 57():119-130. PubMed ID: 33387664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.